Objective:

To showcase advancements in ophthalmic technology, including specific innovations, and foster collaboration among vision care professionals.

Key Findings:

• Day One focused on market strategies for distributors in ophthalmic care, discussing evolving market dynamics.
• Day Two highlighted clinical advancements, including aberrometry in cataract surgery, and encouraged dialogue between distributors and eye doctors.
• Day Three addressed challenges in eye care, including myopia control and dry eye assessment, showcasing cutting-edge technologies.

Interpretation:

The meeting reinforced CSO's leadership in ophthalmic technology and emphasized the importance of collaboration between clinical and commercial stakeholders, particularly in addressing real-world applications.

Limitations:

• The event's insights are based on presentations and discussions, which may not represent comprehensive data or all perspectives in the field, particularly regarding emerging technologies.

Conclusion:

The CSO Meeting 2026 successfully bridged innovation and clinical practice, addressing current challenges in eye care and showcasing future technologies, including strategies for myopia control.